ISRG Valuation

Intuitive Surgical Inc

Add to Watchlist

Advanced Chart

474.260

+5.82(1.242%)1D

Overview
Forecast
Valuation
Earnings

ISRG Relative Valuation

ISRG's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ISRG is overvalued; if below, it's undervalued.

Historical Valuation

Intuitive Surgical Inc (ISRG) is now in the Fair zone, suggesting that its current forward PE ratio of 54.80 is considered Fairly compared with the five-year average of 57.48. The fair price of Intuitive Surgical Inc (ISRG) is between 386.45 to 517.25 according to relative valuation methord.

Relative Value

Fair Zone

386.45-517.25

Current Price：468.44

Fair

54.73

Trailing

Forward

37.15

EV/EBITDA

Intuitive Surgical Inc. (ISRG) has a current EV/EBITDA of 37.15. The 5-year average EV/EBITDA is 38.96. The thresholds are as follows: Strongly Undervalued below 24.32, Undervalued between 24.32 and 31.64, Fairly Valued between 46.29 and 31.64, Overvalued between 46.29 and 53.61, and Strongly Overvalued above 53.61. The current Forward EV/EBITDA of 37.15 falls within the Historic Trend Line -Fairly Valued range.

44.25

EV/EBIT

Intuitive Surgical Inc. (ISRG) has a current EV/EBIT of 44.25. The 5-year average EV/EBIT is 44.36. The thresholds are as follows: Strongly Undervalued below 27.86, Undervalued between 27.86 and 36.11, Fairly Valued between 52.61 and 36.11, Overvalued between 52.61 and 60.86, and Strongly Overvalued above 60.86. The current Forward EV/EBIT of 44.25 falls within the Historic Trend Line -Fairly Valued range.

16.09

Intuitive Surgical Inc. (ISRG) has a current PS of 16.09. The 5-year average PS is 16.53. The thresholds are as follows: Strongly Undervalued below 10.43, Undervalued between 10.43 and 13.48, Fairly Valued between 19.58 and 13.48, Overvalued between 19.58 and 22.63, and Strongly Overvalued above 22.63. The current Forward PS of 16.09 falls within the Historic Trend Line -Fairly Valued range.

40.08

P/OCF

Intuitive Surgical Inc. (ISRG) has a current P/OCF of 40.08. The 5-year average P/OCF is 43.29. The thresholds are as follows: Strongly Undervalued below 27.86, Undervalued between 27.86 and 35.58, Fairly Valued between 51.01 and 35.58, Overvalued between 51.01 and 58.72, and Strongly Overvalued above 58.72. The current Forward P/OCF of 40.08 falls within the Historic Trend Line -Fairly Valued range.

51.07

P/FCF

Intuitive Surgical Inc. (ISRG) has a current P/FCF of 51.07. The 5-year average P/FCF is 59.58. The thresholds are as follows: Strongly Undervalued below 40.77, Undervalued between 40.77 and 50.18, Fairly Valued between 68.99 and 50.18, Overvalued between 68.99 and 78.39, and Strongly Overvalued above 78.39. The current Forward P/FCF of 51.07 falls within the Historic Trend Line -Fairly Valued range.

Intuitive Surgical Inc (ISRG) has a current Price-to-Book (P/B) ratio of 9.43. Compared to its 3-year average P/B ratio of 9.75 , the current P/B ratio is approximately -3.37% higher. Relative to its 5-year average P/B ratio of 9.53, the current P/B ratio is about -1.11% higher. Intuitive Surgical Inc (ISRG) has a Forward Free Cash Flow (FCF) yield of approximately 1.17%. Compared to its 3-year average FCF yield of 0.83%, the current FCF yield is approximately 40.72% lower. Relative to its 5-year average FCF yield of 1.08% , the current FCF yield is about 7.90% lower.

9.41

P/B

Median3y

9.75

Median5y

9.53

1.19

FCF Yield

Median3y

0.83

Median5y

1.08

Competitors Valuation Multiple

The average P/S ratio for ISRG's competitors is 7.09, providing a benchmark for relative valuation. Intuitive Surgical Inc Corp (ISRG) exhibits a P/S ratio of 16.09, which is 126.93% above the industry average. Given its robust revenue growth of 21.40%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

ISRG.O

Intuitive Surgical Inc

Boston Scientific Corp

Thermo Fisher Scientific Inc

Performance Decomposition

Market capitalization of ISRG decreased by 3.73% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 2.01B to 2.44B.

The secondary factor is the Margin Expansion, contributed 2.95%to the performance.

Overall, the performance of ISRG in the past 1 year is driven by Revenue Growth. Which is more sustainable.

21.40%

2.01B → 2.44B

Revenue Growth

2.95%

26.44 → 27.22

Margin Expansion

-28.08%

90.91 → 65.38

P/E Change

-3.73%